Author:
Cabrera-Salazar Mario A.,Cheng Seng H.
Reference57 articles.
1. Atchison RW, Casto BC, Hammon WM., 1965, Adenovirus associated defective virus particles. Science 49:754.
2. Barbon CM, Ziegler RJ, Li C, Armentano D, Cherry M, Desnick RJ, Schuchman EH, Cheng SH., 2005, AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann-Pick disease. Mol Ther. 3:431.
3. Barranger JA., 1984, Marrow transplantation in genetic disease. N Engl J Med. 311:1629.
4. Bessis N, Garcia-Cozar FJ, Boissier MC., 2004, Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene Ther. Suppl 1:S10-7.
5. Blankinship MJ, Gregorevic P, Chamberlain JS., 2006, Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors. Mol Ther. 2:241-9.